These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. Chessa M; Carminati M; Cao QL; Butera G; Giusti S; Bini RM; Hijazi ZM J Invasive Cardiol; 2002 Jun; 14(6):322-7. PubMed ID: 12042624 [TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry. Holzer R; Balzer D; Amin Z; Ruiz CE; Feinstein J; Bass J; Vance M; Cao QL; Hijazi ZM Catheter Cardiovasc Interv; 2004 Feb; 61(2):196-201. PubMed ID: 14755811 [TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of a ventricular septal defect following myectomy for hypertrophic obstructive cardiomyopathy. Spies C; Ujivari F; Schraeder R Cardiology; 2009; 112(1):31-4. PubMed ID: 18577883 [TBL] [Abstract][Full Text] [Related]
12. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. Holzer R; Balzer D; Cao QL; Lock K; Hijazi ZM; J Am Coll Cardiol; 2004 Apr; 43(7):1257-63. PubMed ID: 15063439 [TBL] [Abstract][Full Text] [Related]
13. [Percutaneous closure of ductus arteriosus and muscular ventricular defect with amplatzer occluder in a patient with severe pulmonary hypertension]. García-Montes JA; Zabal Cerdeira C; Calderón-Colmenero J; Espínola N; Fernández de la Reguera G; Buendía Hernández A Arch Cardiol Mex; 2005; 75(3):320-6. PubMed ID: 16294822 [TBL] [Abstract][Full Text] [Related]
14. Transcatheter closure of a non-restrictive patent ductus arteriosus with an Amplatzer muscular ventricular septal defect occluder. Eicken A; Balling G; Gildein HP; Genz T; Kaemmerer H; Hess J Int J Cardiol; 2007 Apr; 117(1):e40-2. PubMed ID: 17196689 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience. Szkutnik M; Kusa J; Białkowski J Kardiol Pol; 2008 Sep; 66(9):941-7; discussion 948-9. PubMed ID: 18924021 [TBL] [Abstract][Full Text] [Related]
16. A case of hemolysis after percutaneous ventricular septal defect closure with a device. Martinez MW; Mookadam M; Mookadam F J Invasive Cardiol; 2007 Jul; 19(7):E192-4. PubMed ID: 17620685 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous closure of ventricular septal defects. State of the art. Butera G; Chessa M; Carminati M J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):39-45. PubMed ID: 17255815 [TBL] [Abstract][Full Text] [Related]